Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Immanuel Seitz

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Klinische Monatsblatter Fur Augenheilkunde|February 21, 2022
Importance of Nonhuman Primates as a Model System for Gene Therapy Development in OphthalmologyFabian Wozar, Immanuel Seitz, Felix Reichel, et al.
Ophthalmology Science|October 17, 2022
An Optimized Treatment Protocol for Subretinal Injections Limits Intravitreal Vector DistributionFelix F L Reichel, Fabian Wozar, Immanuel Seitz, et al.
Journal of Refractive Surgery (Thorofare, N.J. : 1995)|February 10, 2026
Surgical Approach for the Implantation of a Ring Electrode into the Sulcus in a Phakic Non-human PrimateFriederike C Kortuem, Immanuel Seitz, Sebastian Kaltenstadler, et al.
The British Journal of Ophthalmology|May 24, 2022
Development of retinal atrophy after subretinal gene therapy with voretigene neparvovecFelix Friedrich Reichel, Immanuel Seitz, Fabian Wozar, et al.
The British Journal of Ophthalmology|May 19, 2021
Three-year results of phase I retinal gene therapy trial for CNGA3-mutated achromatopsia: results of a non randomised controlled trialFelix Friedrich Reichel, Stylianos Michalakis, Barbara Wilhelm, et al.
The British Journal of Ophthalmology|August 18, 2025
Safety and vision outcomes of subretinal gene supplementation therapy in <i>PDE6A</i>-associated retinitis pigmentosa: a non-randomised controlled trialFelix F Reichel, M Dominik Fischer, Katarina Stingl, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Klinische Monatsblatter Fur Augenheilkunde|February 21, 2022
Importance of Nonhuman Primates as a Model System for Gene Therapy Development in OphthalmologyFabian Wozar, Immanuel Seitz, Felix Reichel, et al.
Ophthalmology Science|October 17, 2022
An Optimized Treatment Protocol for Subretinal Injections Limits Intravitreal Vector DistributionFelix F L Reichel, Fabian Wozar, Immanuel Seitz, et al.
Journal of Refractive Surgery (Thorofare, N.J. : 1995)|February 10, 2026
Surgical Approach for the Implantation of a Ring Electrode into the Sulcus in a Phakic Non-human PrimateFriederike C Kortuem, Immanuel Seitz, Sebastian Kaltenstadler, et al.
The British Journal of Ophthalmology|May 24, 2022
Development of retinal atrophy after subretinal gene therapy with voretigene neparvovecFelix Friedrich Reichel, Immanuel Seitz, Fabian Wozar, et al.
The British Journal of Ophthalmology|May 19, 2021
Three-year results of phase I retinal gene therapy trial for CNGA3-mutated achromatopsia: results of a non randomised controlled trialFelix Friedrich Reichel, Stylianos Michalakis, Barbara Wilhelm, et al.
The British Journal of Ophthalmology|August 18, 2025
Safety and vision outcomes of subretinal gene supplementation therapy in <i>PDE6A</i>-associated retinitis pigmentosa: a non-randomised controlled trialFelix F Reichel, M Dominik Fischer, Katarina Stingl, et al.
Pageof 1